Expertise in
2
conditions

Sean M. Wharton

Burlington, ON, CA 
Expertise in
2
conditions
Burlington, ON, CA 
OverviewLocationsClinical Research

Overview

Sean Wharton practices in Burlington, Canada. Mr. Wharton is highly rated in 2 conditions, according to our data. His top areas of expertise are Obesity, Type 2 Diabetes (T2D), Metabolic Syndrome, and Hypolipoproteinemia.

His clinical research consists of co-authoring 91 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years.

Gender
Male

Locations

Burlington, ON, Canada
Other Locations
Hamilton, ON, Canada
Toronto, ON, Canada
Toronto, Canada

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Phase 2 Study of Once-Daily LY3502970 Compared With Placebo in Participants Who Have Obesity or Are Overweight With Weight-Related Comorbidities
A Phase 2 Study of Once-Daily LY3502970 Compared With Placebo in Participants Who Have Obesity or Are Overweight With Weight-Related Comorbidities
Enrollment Status: Completed
Publish Date: September 13, 2023
Intervention Type: Drug
Study Drug: LY3502970
Study Phase: Phase 2
Compassion-focused Intervention for Women With Mood Disorders Seeking Treatment for Obesity
Compassion-focused Intervention for Women With Mood Disorders Seeking Treatment for Obesity
Enrollment Status: Completed
Publish Date: June 02, 2023
Intervention Type: Behavioral
Study Phase: Not Applicable
A Randomized, Double Blind, Placebo Controlled Trial Evaluating the Effects of a Highly Viscous Non-starch Polysaccharide (PolyGlycopleX® - PGX®), on Glycemic Control, Cardiometabolic Risk Factors and Weight Loss in Overweight and Obese Type II Diabetics Enrolled in a Medically Supervised Weight Management Program.
A Randomized, Double Blind, Placebo Controlled Trial Evaluating the Effects of a Highly Viscous Non-starch Polysaccharide (PolyGlycopleX® - PGX®), on Glycemic Control, Cardiometabolic Risk Factors and Weight Loss in Overweight and Obese Type II Diabetics Enrolled in a Medically Supervised Weight Management Program.
Enrollment Status: Terminated
Publish Date: February 11, 2021
Intervention Type: Dietary supplement
Study Phase: Phase 3
View 2 Less Clinical Trials

89 Total Publications

Orforglipron, an Oral Small-Molecule GLP-1 Receptor Agonist for Obesity Treatment.
Orforglipron, an Oral Small-Molecule GLP-1 Receptor Agonist for Obesity Treatment.
Journal: The New England journal of medicine
Published: September 17, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Wharton's expertise for a condition
ConditionClose
    View All 7 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile